Peter Rahmer - May 30, 2023 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Title: Chief Corporate Development Officer
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
May 30, 2023
Transactions value $
$0
Form type
4
Date filed
6/1/2023, 06:24 PM
Previous filing
Jun 1, 2023
Next filing
Jun 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Award $0 +162K +103.34% $0.00 318K May 30, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F2 Includes 291,332 shares underlying RSUs.

Remarks:

Title: Chief Corporate Development Officer